
|Articles|August 19, 2014
- Immunotherapy (Issue 3)
- Volume 3
- Issue 1
The Management of Side Effects Associated With Immunotherapies
Author(s)Jedd D. Wolchok, MD, PhD
Jedd D. Wolchok, MD, PhD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the management of side effects associated with immunotherapies.
Advertisement
Jedd D. Wolchok, MD, PhD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the management of side effects associated with immunotherapies.
View more about managing side effects and the limitations of immunotherapies > >
Articles in this issue
about 11 years ago
A Brief History of Immunotherapyabout 11 years ago
Better Biomarker Testing Needed in Immuno-Oncologyabout 11 years ago
Autoimmunity and Limitations of Cancer Vaccinesabout 11 years ago
The Next Wave in Immunotherapy: Combinationsabout 11 years ago
Future Immune Checkpoint StrategiesAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
The Targeted Pulse: FDA Decisions and Clinical Advancements
2
FDA Accepts NDA for 177Lu-edotreotide in GEP-NETs
3
Long-Term Follow-Up Confirms Benefits of Low-Dose Seminoma Treatment
4
Rethinking Advanced Prostate Cancer: Surprising Finds from a Landmark Study
5







































